TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [08/11/2025 12:23 PDT] TELA Bio, Inc. (NASDAQ:TELA), Up By 100% ($1.85) From $1.85 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [08/05/2025 07:22 PDT] sector Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.
• [07/22/2025 07:21 PDT] TELA Expected to Trade Up After Bullish Patterns Develop
• [07/11/2025 07:28 PDT] sector Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.
• [07/11/2025 07:25 PDT] TELA Expected to Trade Up After Bullish Patterns Develop
• [06/24/2025 11:46 PDT] TELA Bio, Inc. (NASDAQ:TELA), Up By 100% ($1.65) From $1.65 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [06/23/2025 07:25 PDT] sector Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.